WA
PCRX icon

WPG Advisers’s Pacira BioSciences PCRX Stock Holding History

WPG Advisers’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.38K Sell
291
-83
-22% -$1.96K ﹤0.01% 867
2026
Q1 		$8.45K Hold
374
– – 0.01% 732
2025
Q4 		$9.68K Buy
374
+291
+351% +$6.92K 0.01% 710
2025
Q3 		$2.14K Hold
83
– – ﹤0.01% 1122
2025
Q2 		$1.98K Hold
83
– – ﹤0.01% 1120
2025
Q1 		$2.06K Sell
83
-71
-46% -$1.7K ﹤0.01% 1110
2024
Q4 		$2.9K Buy
+154
New +$2.7K ﹤0.01% 988

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

WPG Advisers's PCRX Position: Q2 2026 in Review

WPG Advisers reduced its Pacira BioSciences (PCRX) stake by 22% in Q2 2026, selling an estimated $1.96K and leaving 291 shares worth $7.38K. The position accounts for ﹤0.01% of the portfolio, ranked #867.

WPG Advisers first reported a position in PCRX in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.68K in Q4 2025. 97 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • WPG Advisers held 291 shares of Pacira BioSciences worth $7.38K as of Q2 2026.
  • WPG Advisers sold 83 Pacira BioSciences shares in Q2 2026, an estimated $1.96K.
  • Pacira BioSciences made up ﹤0.01% of WPG Advisers's portfolio in Q2 2026, its #867 holding.
  • WPG Advisers first reported a position in Pacira BioSciences in Q4 2024 and has held it in 7 quarters since.
  • WPG Advisers's Pacira BioSciences position peaked at $9.68K in Q4 2025.
  • 97 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.